Cervical cancer can and should be prevented.

TruScreen provides an accurate, real-time primary screening solution. 
Our screening solution is ideal for communities that can’t access conventional laboratory-based screening methods. It is affordable and easy to learn.

Our purpose is to ensure that all women of screening age – no matter who or where they are – have access to quality screening.

TruScreen manufactures and owns all rights to the TruScreen Cervical Cancer Screening System. The system comprises a medical device and AI-enabled process designed to detect, in real-time, the presence of pre-cancerous and cancerous tissue on the cervix.

TruScreen’s focus markets are low and-middle income countries (LMICs) where there is a lack of organised cervical cancer screening and the required infrastructure.

Find out more about the company